高等学校化学学报 ›› 2015, Vol. 36 ›› Issue (9): 1694.doi: 10.7503/cjcu20150404

• 有机化学 • 上一篇    下一篇

嘧啶联苯类化合物的设计、 合成及抗肿瘤活性

周皓, 段志刚, 赵爽, 宝梅英, 李志伟(), 裴亚中()   

  1. 组合化学与创新药物研究中心, 吉林大学药学院, 长春 130021
  • 收稿日期:2015-05-20 出版日期:2015-09-10 发布日期:2015-08-21
  • 作者简介:联系人简介: 裴亚中, 男, 博士, 教授, 博士生导师, 主要从事多样化合成与创新药物研究. E-mail:peiyz@jlu.edu.cn;李志伟, 男, 博士, 教授, 博士生导师, 主要从事生物和药物筛选研究. E-mail:zwl.jida@gmail.com
  • 基金资助:
    国家自然科学基金(批准号: 81172914, 81071743)、 吉林大学唐敖庆教授启动资金和吉林省人才开发基金资助

Design and Synthesis of Phenylpyrimidine and Their Anticancer Activity

ZHOU Hao, DUAN Zhigang, ZHAO Shuang, BAO Meiying, LI Zhiwei*(), PEI Yazhong*()   

  1. Center for Combinatorial Chemistry and Drug Discovery, School of Pharmaceutical Sciences,Jilin University, Changchun 130021, China
  • Received:2015-05-20 Online:2015-09-10 Published:2015-08-21
  • Contact: LI Zhiwei,PEI Yazhong E-mail:zwl.jida@gmail.com;peiyz@jlu.edu.cn
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.81172914, 81071743), the Tang Aoqing Professorship Research Grant from Jilin University, China and the Jilin Province Talent Development Program, China

摘要:

设计合成了一系列以嘧啶联苯为中心结构的潜在激酶变构抑制剂. 以2,4-二氯-5-甲基嘧啶为起始原料, 通过Suzuki偶联一锅法合成了中心药效团嘧啶联苯, 通过X射线单晶衍射分析确认结构, 并在此基础上衍生化合成了19个化合物. 采用噻唑蓝(MTT)法对所得化合物用人乳腺癌细胞(MCF-7)进行体外抗肿瘤活性初步筛选, 并找到2个具有潜在应用价值的化合物8c(IC50=0.224 μmol/L)和9c(IC50=0.113 μmol/L).

关键词: 嘧啶联苯, 蛋白激酶, 变构抑制剂, 抗肿瘤活性

Abstract:

Allosteric kinase inhibitors modulate kinase activities by inducing and stabilizing the inactive conformations of the targets. In comparison to ATP competitive inhibitors, this type inhibitors exhibit better selectivity and higher efficacy, and have shown to be safe and effective treatments for various forms of cancers in the clinics. Based on the X-ray co-crystal structures of reported allosteric kinase inhibitors bound to thecorresponding protein kinases, a bi-cyclic pharmacophore model was proposed. 19 new phenylpyrimidine derivatives were designed and synthesized from 2,4-diamino-5-methylpyrimidine. The inhibitory effects of these compounds against human breast cancer cell(MCF-7) proliferation were evaluated using MTT method. The leader compounds, 8c and 9c, were identified showing IC50 of 0.224 and 0.113 μmol/L, respectively.

Key words: Phenylpyrimidine, Protein kinase, Allosteric kinase inhibitor, Antitumor activity

中图分类号: 

TrendMD: